Skip to main content

Table 2 Eye-level characteristics by STA success or failure

From: Risk factors for failing sub-Tenon’s triamcinolone acetonide for uveitic macular edema

 

All Patient Eyes

n (column %)

STA Success

n (column %)

STA Failure

n (column %)

% Failure

(Row %)

P-value

Number of patients (row %)

180

138

42

23.3%

Use of topical corticosteroids

99 (55.0%)

69 (50.0%)

30 (71.4%)

30.3%

0.039

Presence of intra-retinal cystoid spaces

     

 Yes

119 (66.1%)

90 (65.2%)

29 (69.0%)

24.4%

0.604

 No

57 (31.7%)

46 (33.3%)

11 (26.2%)

19.3%

 

 Missinga

4 (2.2%)

2 (1.4%)

2 (4.8%)

50.0%

 

Presence of sub-retinal fluid

     

 Yes

21 (11.7%)

14 (10.1%)

7 (16.7%)

33.3%

0.139

 No

155 (86.1%)

122 (88.4%)

33 (78.6%)

21.3%

 

 Missinga

4 (2.2%)

2 (1.4%)

2 (4.8%)

50.0%

 

CST, um

n = 172

n = 134

n = 38

  

 Mean (SD)

316 (113)

299 (93.8)

374 (152)

 

0.002

 Median (range)

278 (156, 749)

276 (156, 700)

332 (186, 749)

  

CST, tertile category

     

 156–256

57 (33.1%)

47 (35.1%)

10 (26.3%)

17.5%

0.068

 256- < 330

63 (36.6%)

54 (40.3%)

9 (23.7%)

14.3%

0.008

 331–749

52 (30.2%)

33 (24.6%)

19 (50.0%)

36.5%

Reference

Petalloid macular leakage on FA

     

 Yes

127 (70.6%)

103 (74.6%)

24 (57.1%)

18.9%

Reference

 Nob

6 (3.3%)

6 (4.4%)

0

0%

 No FA

47 (26.1%)

29 (21.0%)

18 (42.9%)

38.3%

0.012

  1. STA sub-Tenon’s triamcinolone acetonide, CST central subfield thickness, SD standard deviation, FA fluorescein angiography
  2. aMissing data not included in statistical comparisons
  3. bNo petalloid macular leakage on FA was not included in statistical comparisons due to zero cell size